The gynecologic oncologists have expertise in treating many types of female pelvic cancers including cancers of the ovary, uterus, cervix, vulva and trophoblast (placenta). The scope of services provided includes screening examinations; diagnostic imaging; treatment of gynecologic cancer including surgery, radiation therapy, and/or medical oncology; outpatient chemotherapy; counseling services; innovative plastic reconstructive surgery and second opinions for women with gynecologic cancer.
- Ovarian Cancer
- Peritoneal Cancer
- Cervical Cancer
- Endometrial Cancer
- Fallopian Tube Cancer
- Peritoneal Tube Cancer
- Vaginal Cancer
- Vulvar Cancer
- Undiagnosed Pelvic Mass
- Consultation for Advanced Metastatic Cancer
- Family History of Gynecological Cancer
- Molar Pregnancy
- Gestational Trophoblastic Disease
What Sets us Apart
Clinic Locations
1825 Fourth St., Sixth Floor
San Francisco, CA94158
United States
1600 Divisadero St., Fourth Floor
San Francisco, CA94115
United States
3100 San Pablo Ave., Suite 280
Berkeley, CA 94702, CA94702
United States
1100 S. Eliseo Dr., Suite 1
Greenbrae, CA94904
United States
2356 Sutter Street, 7th Flr.
San Francisco, CA94143
United States
Bakar Precision Cancer Medicine Building
1825 Fourth Street, 3rd Fl. San Francisco
San Francisco, CA94158
United States
Leading the Conversation
Engineered immune cells. Supercharged scans. Drug implants. Gene manipulators. Blood biopsies. A flurry of innovations could change how we confront cancer.
Learn about strategies for communicating with your care team, managing long-term effects of radiation, art for recovery and more.
Endometrial Cancer: Molecular Classification, Genetics, When to Rebiopsy, and What's New in the Research
Z. Mike Chirenje, MD FRCOG
Professor, Ob/Gyn,
Department of Obstetrics and Gynecology and Reproductive Sciences
University of California, San Francisco
Completing standard of care concurrent chemoradiation therapy and brachytherapy in the recommended 8 weeks was associated with a superior overall survival. Patients who received brachytherapy boost show superior survival to patients receiving EBRT alone, regardless of treatment duration. Disparities in care for vulnerable populations highlight the challenges and importance of care coordination for patients with cervical cancer.
DNA fragments circulating in the blood are often present in people with cancer. Current tests using DNA fragments circulating in the blood have limitations in detecting cancer. We developed a cancer diagnostic approach that uses neomers, short DNA sequences that are mostly absent in healthy individuals but are present in tumors as a consequence of changes in the DNA (DNA mutations) in cancer cells.
Comprehensive longitudinal characterization of ovarian cancer identifies pathways that promote tumorigenesis and provides insights into regulators of chemotherapy response, which could help develop strategies to improve outcomes for patients.
COPS5 depletion or inhibition using a small molecule COPS5 inhibitor CSN5i-3 sensitizes high-grade serous carcinoma to platinum chemotherapy through downregulation of nucleotide excision repair and interstrand crosslink repair.